Funding for this research was provided by:
British Heart Foundation (FS/16/54/32730)
Chief Scientist Office (TCS/16/37)
Article History
Received: 11 March 2019
Accepted: 9 July 2019
First Online: 18 July 2019
Ethics approval and consent to participate
: This is a review article requiring no ethics approval or consent.
: All authors agree to publication.
: David Hay is a co-founder and shareholder in Stemnovate Limited and Higher Steaks Limited. The other authors declare that they have no competing interests.